Skip to content

Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ Prolapse

Pelvic Organ Prolapse Correction Plus Preventive Treatment of Urinary Stress Incontinence vs. Correction of Pelvic Organ Prolapse Followed by Treatment of Urinary Stress Incontinence

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00697489
Enrollment
0
Registered
2008-06-16
Start date
2008-06-30
Completion date
Unknown
Last updated
2013-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Pelvic organ prolapse, Urinary incontinence, Mesh

Brief summary

The incidence of pelvic organ prolapse (POP) in parous women is estimated over 50%. A variety of urinary, bowel and sexual symptoms may be associated with POP. Moreover, a proportion of women who underwent a surgical correction of POP may occur post-surgical urinary incontinence and, thus, if this last presents as genuine stress-type or mixed-type, a second surgical intervention may be required. At this proposal, with the aim to reduce the incidence of postoperative urinary incontinence, the addition of a preventive continence procedure to a POP repair intervention has been widely proposed, but the potential benefits needs to be balanced against potential disadvantages. Based on these considerations, the aim of this trial will be to compare two different surgical strategies for women with POP without urinary stress incontinence. Specifically, the efficacy to associate and to follow a preventive continence procedure to the correction of POP will be compared.

Detailed description

Women with POP not associated to urinary stress incontinence will be enrolled and randomized in two arms(groups A and B). Patients of group A will be treated with unique surgery (correction of POP plus preventive continence procedure), whereas in patients of group B POP will be surgically corrected and, in case of stress or mixed postoperative incontinence, a further intervention for urinary stress incontinence will be tailored. All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, ultrasonographic and urodynamic evaluations. During the study, the clinical outcomes, and the adverse experience will be evaluated in each patient. Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Interventions

PROCEDUREcorrection of POP plus preventive continence procedure
PROCEDUREPOP surgery followed by eventual incontinence procedure

Sponsors

University Magna Graecia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pelvic organ prolapse stage 2-3 * Absence of subjective urinary stress incontinence

Exclusion criteria

* pregnancy * \<12 months postpartum * systemic disease known to affect bladder function * current chemotherapy or radiation therapy * urethral diverticulum, augmentation cytoplasty, or artificial sphincter * recent pelvic surgery * patient age under 18 and over 80 * any previous pelvic surgery, diabetes mellitus and collagen disease

Design outcomes

Primary

MeasureTime frame
efficacy (cure rate)12 months

Secondary

MeasureTime frame
postoperative complications rate12 months
sexual function12 months
intra-operative complication rateone day
Failure rate12 months
Recurrence rate12 months
quality of life12 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026